170 related articles for article (PubMed ID: 37163449)
1. V-Set Immunoglobulin Domain-Containing Protein 4 as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology Activity.
Tang C; Zhang S; Teymur A; Yang B; Nazir F; Cai Q; Saxena R; Olsen NJ; Mohan C; Wu T
Arthritis Rheumatol; 2023 Sep; 75(9):1573-1585. PubMed ID: 37163449
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
3. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
[TBL] [Abstract][Full Text] [Related]
4. Urinary ferritin creatinine ratio, a potential biomarker for lupus nephritis activity.
Qi L; Xu J; Yang C; Hou X; Yang P
Clin Rheumatol; 2021 Jan; 40(1):143-149. PubMed ID: 32557256
[TBL] [Abstract][Full Text] [Related]
5. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
[TBL] [Abstract][Full Text] [Related]
6. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
7. Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis.
Ding H; Shen Y; Lin C; Qin L; He S; Dai M; Okitsu SL; DeMartino JA; Guo Q; Shen N
Arthritis Res Ther; 2022 Mar; 24(1):77. PubMed ID: 35346341
[TBL] [Abstract][Full Text] [Related]
8. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
9. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
[TBL] [Abstract][Full Text] [Related]
10. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C
Front Immunol; 2020; 11():671. PubMed ID: 32351512
[TBL] [Abstract][Full Text] [Related]
11. Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays.
Stanley S; Mok CC; Vanarsa K; Habazi D; Li J; Pedroza C; Saxena R; Mohan C
Arthritis Rheumatol; 2019 May; 71(5):744-755. PubMed ID: 30618193
[TBL] [Abstract][Full Text] [Related]
12. Using plasma circRNA_002453 as a novel biomarker in the diagnosis of lupus nephritis.
Ouyang Q; Huang Q; Jiang Z; Zhao J; Shi GP; Yang M
Mol Immunol; 2018 Sep; 101():531-538. PubMed ID: 30172209
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the Role of Urinary Heparanase in Lupus Nephritis Patients and Its Correlation with Disease Activity.
Abou-Alfa MA; Abdel Noor RA; Nagy HM; Kotb NA
Saudi J Kidney Dis Transpl; 2022 Nov; 33(6):746-754. PubMed ID: 38018716
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-2 as a biomarker for lupus nephritis.
Luong PT; Nguyen TTD; Nguyen NT; Ngo HT; Nguyen HN; Pho DH; Nguyen HT
Pediatr Int; 2023; 65(1):e15613. PubMed ID: 37698235
[TBL] [Abstract][Full Text] [Related]
15. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
16. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.
Go DJ; Lee JY; Kang MJ; Lee EY; Lee EB; Yi EC; Song YW
Lupus; 2018 Sep; 27(10):1600-1615. PubMed ID: 29958502
[TBL] [Abstract][Full Text] [Related]
17. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
Badr AMM; Farag Y; Abdelshafy M; Riad NM
Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
[TBL] [Abstract][Full Text] [Related]
18. Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis.
Soliman SA; Stanley S; Vanarsa K; Ismail F; Mok CC; Mohan C
Front Immunol; 2022; 13():910993. PubMed ID: 36091001
[TBL] [Abstract][Full Text] [Related]
19. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
20. Renal interferon-inducible protein 16 expression is associated with disease activity and prognosis in lupus nephritis.
Wang X; Fu S; Yu J; Ma F; Zhang L; Wang J; Wang L; Tan Y; Yi H; Wu H; Xu Z
Arthritis Res Ther; 2023 Jul; 25(1):112. PubMed ID: 37393341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
